Skip to content

Clinical Efficacy and Underlying Mechanisms of Combined Magnetic Therapy and Exercise Snacks Intervention in Elderly Patients with Sarcopenia

Clinical Efficacy and Underlying Mechanisms of Combined Magnetic Therapy and Exercise Snacks Intervention in Elderly Patients with Sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114561
Enrollment
Unknown
Registered
2025-12-15
Start date
2025-12-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Control Group:Usual Care
Magnetic Intervention Only Group:Usual Care + LF-PEMF Intervention Group
Combined Intervention Group:Usual Care + "Exercise Snacks" + LF-PEMF Intervention Group

Sponsors

Jinqiu Hospital of Liaoning Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 60 years. 2.Meeting the diagnostic criteria for sarcopenia according to the Chinese Guidelines for Diagnosis and Treatment of Sarcopenia (2024 edition): Low Muscle Mass: DXA: Appendicular Skeletal Muscle Index (ASMI) = 12 seconds. 3.No major joint injuries or history of magnetic vertigo within the past 6 months. 4.No presence of magnetic field-sensitive devices, such as cardiac pacemakers or metal implants. 5.A score >= 12 on the Mini Nutritional Assessment (MNA) scale (excluding severe malnutrition). 6.Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Presence of severe cardiac, hepatic, or renal diseases, active malignant tumors, or primary neuromuscular diseases. 2.Cognitive or physical impairment that would preclude the ability to comply with the prescribed exercise or magnetic field interventions. 3.Known allergy to nutritional supplements such as whey protein or vitamin D. 4.Participation in systematic sarcopenia-related interventions (e.g., regular resistance training, targeted muscle nutrition supplementation) within the past 3 months. 5.History of severe lower limb fracture, tendon/ligament reconstruction surgery within the past 6 months, or presence of unhealed soft tissue injuries. 6.Known allergy to components of the trial equipment or related accessories (e.g., electrode gel, patch materials). 7.Any other condition deemed by the investigator to render the subject unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Appendicular Skeletal Muscle Mass (ASM);Handgrip Strength;

Secondary

MeasureTime frame
Short Physical Performance Battery (SPPB);

Countries

China

Contacts

Public ContactMingyan Bian

Jinqiu Hospital of Liaoning Province

bianmingyan@126.com+86 177 4007 8171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026